Correvio slumps after FDA say benefits of heart drug do not outweigh risks
07 Dec 2019 //
REUTERS
Correvio partner begins patient enrollment in ph 3 study on Brinavess in China
18 May 2018 //
PHARMABIZ
FDA throws up another roadblock to Cardiome, 9 years after rejecting its drug
23 Aug 2017 //
ENDPTS